Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis.

Seminars in thrombosis and hemostasis

Volumn 35, Issue 7, 2009, Pages 613-620

  Mak, Winifred ^a   Dokras, Anuja ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; C REACTIVE PROTEIN; HOMOCYSTEINE; ORAL CONTRACEPTIVE AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE1 PROTEIN, HUMAN;

BLOOD; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; FEMALE; HUMAN; METABOLISM; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; VEIN THROMBOSIS;

ADIPONECTIN; BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COMORBIDITY; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HOMOCYSTEINE; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYCYSTIC OVARY SYNDROME; RISK FACTORS; VENOUS THROMBOSIS;

EID: 77449124834     PISSN: None     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1242715     Document Type: Review

References (83)